Ayrshire Capital Management LLC Abbott Laboratories Transaction History

Ayrshire Capital Management LLC

$193 Million
Q4 2024

A detailed history of Ayrshire Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ayrshire Capital Management LLC holds 45,227 shares of ABT stock, worth $6.1 Million. This represents 2.65% of its overall portfolio holdings.

Number of Shares

45,227

Previous 45,066 0.36%

Holding current value

$6.1 Million

Previous $5.14 Million 0.43%

% of portfolio

2.65%

Previous 2.57%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	BUY	$111.93 - $119.39 $18,020 - $19,221	161 Added 0.36%	45,227 $5.12 Million
Q3 2024 Oct 10, 2024	BUY	$100.07 - $118.13 $54,237 - $64,026	542 Added 1.22%	45,066 $5.14 Million
Q2 2024 Jul 22, 2024	BUY	$100.73 - $112.44 $19,037 - $21,251	189 Added 0.43%	44,524 $4.63 Million
Q1 2024 Apr 17, 2024	BUY	$109.52 - $120.96 $643,320 - $710,519	5,874 Added 15.27%	44,335 $5.04 Million
Q4 2023 Jan 09, 2024	SELL	$90.19 - $110.4 $3,427 - $4,195	-38 Reduced 0.1%	38,461 $4.23 Million
Q3 2023 Oct 12, 2023	SELL	$95.53 - $114.62 $852,223 - $1.02 Million	-8,921 Reduced 18.81%	38,499 $3.73 Million
Q2 2023 Jul 14, 2023	SELL	$100.78 - $112.29 $20,156 - $22,458	-200 Reduced 0.42%	47,420 $5.17 Million
Q1 2023 Apr 13, 2023	BUY	$96.86 - $114.01 $11,913 - $14,023	123 Added 0.26%	47,620 $4.82 Million
Q4 2022 Jan 11, 2023	BUY	$95.06 - $111.52 $22,148 - $25,984	233 Added 0.49%	47,497 $0
Q3 2022 Oct 11, 2022	BUY	$96.76 - $112.03 $144,269 - $167,036	1,491 Added 3.26%	47,264 $4.57 Million
Q2 2022 Jul 08, 2022	SELL	$102.07 - $123.37 $137,284 - $165,932	-1,345 Reduced 2.85%	45,773 $4.97 Million
Q1 2022 Apr 19, 2022	BUY	$114.02 - $139.04 $225,417 - $274,882	1,977 Added 4.38%	47,118 $5.58 Million
Q4 2021 Jan 12, 2022	BUY	$115.53 - $141.46 $62,732 - $76,812	543 Added 1.22%	45,141 $6.35 Million
Q3 2021 Oct 12, 2021	SELL	$116.66 - $129.06 $17,149 - $18,971	-147 Reduced 0.33%	44,598 $5.27 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $124,303 - $146,322	1,175 Added 2.7%	44,745 $5.19 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $15,564 - $18,336	143 Added 0.33%	43,570 $5.22 Million
Q4 2020 Jan 21, 2021	BUY	$105.0 - $114.42 $210,840 - $229,755	2,008 Added 4.85%	43,427 $4.76 Million
Q3 2020 Oct 20, 2020	BUY	$91.64 - $111.29 $73,495 - $89,254	802 Added 1.97%	41,419 $4.51 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $165,161 - $211,386	2,157 Added 5.61%	40,617 $3.71 Million
Q1 2020 Apr 17, 2020	BUY	$62.82 - $91.86 $69,039 - $100,954	1,099 Added 2.94%	38,460 $3.04 Million
Q4 2019 Jan 30, 2020	BUY	$78.51 - $87.4 $2.93 Million - $3.27 Million	37,361 New	37,361 $3.25 Million

Others Institutions Holding ABT

# of Institutions

3,361

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ayrshire Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ayrshire Capital Management LLC with notifications on news.

Account

Ayrshire Capital Management LLC Abbott Laboratories Transaction History